Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Measuring the Value of Pharmacogenomics Evidence
View through CrossRef
In recent years, there is a growing need to measure the value of pharmacogenomics testing so that policymakers are well informed to decide about adopting and reimbursing pharmacogenomics testing, prioritizing pharmacogenomics research and development, and encouraging the application of companion diagnostics. Presently, there are limited economic evaluation studies of genome‐guided treatment modalities that would allow decision‐makers to comparatively assess the value and clinical utility of such interventions.
Title: Measuring the Value of Pharmacogenomics Evidence
Description:
In recent years, there is a growing need to measure the value of pharmacogenomics testing so that policymakers are well informed to decide about adopting and reimbursing pharmacogenomics testing, prioritizing pharmacogenomics research and development, and encouraging the application of companion diagnostics.
Presently, there are limited economic evaluation studies of genome‐guided treatment modalities that would allow decision‐makers to comparatively assess the value and clinical utility of such interventions.
Related Results
Knowledge, Attitude and Perception of Pharmacy Students towards Pharmacogenomics and Genetics: An Observational Study from King Saud University
Knowledge, Attitude and Perception of Pharmacy Students towards Pharmacogenomics and Genetics: An Observational Study from King Saud University
Pharmacists are considered among the most accessible healthcare workers in fundamental positions to implement new clinical initiatives, such as pharmacogenomics services. The scope...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
This review summarizes the evidence from six randomized controlled trials that judged the effectiveness of systematic review summaries on policymakers' decision making, or the most...
Clinical Pharmacogenomics
Clinical Pharmacogenomics
Pharmacogenomics is a tool for practitioners to provide precision pharmacotherapy using genomics. All providers are likely to encounter genomic data in practice with the expectatio...
Pharmacogenomics knowledge within Neurology: A brief survey amongst physicians
Pharmacogenomics knowledge within Neurology: A brief survey amongst physicians
Pharmacogenomics has emerged as a tool to optimise treatment. Many neurologists encounter drugs with pharmacogenomic associations with unclear guidelines. We therefore aimed to det...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Pharmacogenomics, Ethics, and Public Policy
Pharmacogenomics, Ethics, and Public Policy
The advent of pharmacogenomics—the study of how the human genome influences drug response within a person or population—has begun to drive the development of pharmaceuticals in Wes...
The Role of Pharmacogenomics in Personalized Drug Therapy
The Role of Pharmacogenomics in Personalized Drug Therapy
Pharmacogenomics is one of the significant new developments in the area of precision medicine, integrating genetic science with pharmacology to tailor drug therapy to individual ge...